50. INITIAL RESULTS OF APPLYING ECMO - V V FOR TREATING PATIENTS WITH SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME AT INTENSIVE CARE DEPARTMENT OF NATIONAL LUNG HOSPITAL IN 2023
Main Article Content
Abstract
Objective: Review the initial results of applying ECMO - VV for treating patients with severe acute respiratory distress syndrome (ARDS) at Intensive Care Department of National Lung Hospital in 2023.
Method: Case-series study design, performed on 13 patients with severe ARDS who were technique applied ECMO - VV at the Intensive Care Department of National Lung Hospital.
Results: 13 ARDS patients were treated with ECMO - VV technique at Intensive Care Department of National Lung Hospital in 2023. The study describes a series of cases. The average age is 53.6 ± 13.5 years old, men account for 8/13. Before ECMO - VV intervention, the average SOFA score was 6.77 ± 1.83. The median duration of ECMO intervention is 5 days, the longest period is 30 days. The most common complications are thrombocytopenia (<80G/l): 9 patients (69.2%); new infections after 48 hours of EMCO treatment, 8 patients (61.5%).
Conclusions: 7 patients (53.8%) were successfully weaned off ECMO. The rate of survival is 6/13. Conclusion: ECMO - VV is a necessary technique to ensure blood oxygenation for severe ARDS patients, is effective in treating the causes of acute respiratory failure.
Article Details
Keywords
Severe Pneumonia, Acute respiratory distress syndrome (ARDS), ECMO – VV.
References
et al., Guidelines on the management of acute
respiratory distress syndrome. BMJ Open Respir
Res, 6(1), 2019.
[2] Bertini P, Guarracino F, Falcone M et al., ECMO
in COVID-19 Patients: A Systematic Review
and Meta-analysis. J Cardiothorac Vasc Anesth,
36(8 Pt A):2700-2706, 2022.
[3] Matthay MA, Arabi Y, Arroliga AC et al., A
New Global Definition of Acute Respiratory Distress
Syndrome. Am J Respir Crit Care Med;209(1):37-47, 2024.
[4] Abrams D, Ferguson ND, Brochard L et
al., ECMO for ARDS:from salvage to standard of care?
The LancetRespiratory Medicine;7:108-10, 2019.
[5] Thomas V, Laurance L, Roberto L et al., Medical
Management of the Adult with Respiratory Failure
on ECLS, Extracorporeal Life Support: The
ELSO Red Book 5th Edition, 449-458. Extracorporeal
Life Support Organization, 2017.
[6] Phạm Thế Thạch, Kết quả điều trị suy hô hấp cấp
tiến triển nặng bằng kỹ thuật ecmo tĩnh mạch -
tĩnh mạch, Tạp chí Nghiên cứu Y học 132 (8)
176-181, 2020.
[7] Vũ Đình Phú, Đồng Phú Khiêm, Phạm Ngọc
Thạch, Kết quả bước đầu áp dụng ECMO - VV
điều trị bệnh nhân suy hô hấp cấp nặng tại Khoa
Hồi sức tích cực Bệnh viện Bệnh nhiệt đới Trung
ương, Tạp chí Truyền nhiễm Việt Nam, 2(30),
2020, 13-18.
[8] Luyt CE, Bouadma L, Morris AC et al., Pulmonary
infections complicating ARDS. Intensive Care Med
46, 2020, 2168–218.
[9] Jiritano F, Serraino GF, Ten Cate H et al., Platelets and
extra-corporeal membrane oxygenation
in adult patients: A systematic review and meta-analysis.
Intensive Care Med;46(6):1154-1169, 2020.